TGIRX
Price
$32.56
Change
-$0.21 (-0.64%)
Updated
Aug 26 closing price
Net Assets
4.28B
VTISX
Price
$162.08
Change
+$0.07 (+0.04%)
Updated
Aug 26 closing price
Net Assets
505.75B
Interact to see
Advertisement

TGIRX vs VTISX

Header iconTGIRX vs VTISX Comparison
Open Charts TGIRX vs VTISXBanner chart's image
Thornburg International Equity R6
Price$32.56
Change-$0.21 (-0.64%)
VolumeN/A
Net Assets4.28B
Vanguard Total Intl Stock Idx Instl Sel
Price$162.08
Change+$0.07 (+0.04%)
VolumeN/A
Net Assets505.75B
TGIRX vs VTISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TGIRX vs. VTISX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGIRX is a Buy and VTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 506B vs. TGIRX (4.28B). VTISX pays higher dividends than TGIRX: VTISX (2.87) vs TGIRX (1.65). TGIRX was incepted earlier than VTISX: TGIRX (13 years) vs VTISX (9 years). TGIRX (0.91) is less costly to investors than VTISX (0.05). TGIRX is a more actively managed with annual turnover of: 43.13 vs. VTISX (3.00). TGIRX has a lower initial minimum investment than VTISX: TGIRX (0) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 14.50 vs. TGIRX (13.77). VTISX return over 5 years is better than : 39.14 vs. TGIRX (35.39).
TGIRXVTISXTGIRX / VTISX
Total Expense Ratio0.700.051,489%
Annual Report Gross Expense Ratio0.910.051,936%
Fund Existence13 years9 years-
Gain YTD25.52021.707118%
Front LoadN/AN/A-
Min. Initial Investment03000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.28B506B1%
Annual Yield % from dividends1.652.8757%
Returns for 1 year13.7714.5095%
Returns for 3 years64.1141.62154%
Returns for 5 years35.3939.1490%
Returns for 10 years23.82N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RAPP16.011.38
+9.43%
Rapport Therapeutics Inc.
GMAB24.540.23
+0.95%
Genmab A/S ADS
PAYO6.76-0.02
-0.29%
Payoneer Global
PMCB1.01-0.01
-1.42%
PharmaCyte Biotech
CSBR6.73-0.33
-4.67%
Champions Oncology